2024 |
Adaptive Biotechnologies Corp
|
Independent Director |
325 K |
0.0 % |
2024 |
Recursion Pharmaceuticals Inc - Ordinary Shares - Class A
|
Chairman of the Board |
316.5 K |
4.5 % |
2024 |
Fate Therapeutics Inc
|
Independent Director |
35.0 K |
- |
2024 |
HilleVax Inc
|
Chairman of the Board, President and Chief Executi |
- |
- |
2023 |
Adaptive Biotechnologies Corp
|
Independent Director |
325.0 K |
4.4 % |
2023 |
Recursion Pharmaceuticals Inc - Ordinary Shares - Class A
|
Independent Director |
302.7 K |
3.3 % |
2023 |
Fate Therapeutics Inc
|
Independent Director |
221.8 K |
- |
2023 |
Fate Therapeutics Inc
|
Independent Director |
- |
- |
2022 |
Adaptive Biotechnologies Corp
|
Independent Director |
311.3 K |
1.6 % |
2022 |
Recursion Pharmaceuticals Inc - Ordinary Shares - Class A
|
Independent Director |
293.1 K |
-18.4 % |
2022 |
ARS Pharmaceuticals Inc
|
Independent Director |
142.7 K |
- |
2022 |
Nanostring Technologies Inc
|
Independent Director |
83.2 K |
-69.9 % |
2022 |
Fate Therapeutics Inc
|
Independent Director |
- |
- |
2022 |
HilleVax Inc
|
Chairman of the Board, President and Chief Executi |
- |
- |
2021 |
Fate Therapeutics Inc
|
Independent Director |
435.2 K |
-40.8 % |
2021 |
Recursion Pharmaceuticals Inc - Ordinary Shares - Class A
|
Independent Director |
359.3 K |
-48.5 % |
2021 |
Adaptive Biotechnologies Corp
|
Independent Director |
306.3 K |
40.9 % |
2021 |
Nanostring Technologies Inc
|
Independent Director |
276.3 K |
25.1 % |
2021 |
HilleVax Inc
|
Chairman of the Board, President and Chief Executi |
- |
- |
2020 |
Fate Therapeutics Inc
|
Independent Director |
735.2 K |
- |
2020 |
Recursion Pharmaceuticals Inc - Ordinary Shares - Class A
|
Independent Director |
697.7 K |
- |
2020 |
Nanostring Technologies Inc
|
Independent Director |
220.9 K |
13.3 % |
2020 |
Adaptive Biotechnologies Corp
|
Independent Director |
217.5 K |
144.6 % |
2019 |
Nanostring Technologies Inc
|
Independent Director |
195.0 K |
128.4 % |
2019 |
Adaptive Biotechnologies Corp
|
Independent Director |
88.9 K |
42.0 % |
2018 |
Nanostring Technologies Inc
|
Independent Director |
85.4 K |
-37.6 % |
2018 |
Adaptive Biotechnologies Corp
|
Independent Director |
62.6 K |
- |
2017 |
Nanostring Technologies Inc
|
Independent Director |
136.7 K |
49.3 % |
2016 |
Nanostring Technologies Inc
|
Independent Director |
91.6 K |
-15.2 % |
2015 |
Nanostring Technologies Inc
|
Independent Director |
108.0 K |
- |
2014 |
Nanostring Technologies Inc
|
Independent Director |
- |
- |